Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 8;63(1):99–107. doi: 10.1007/s00280-008-0716-8

Figure 2.

Figure 2

Figure 2a. A patient with cutaneous metastases had dramatic and rapid response shown here from cycle 1 to cycle 3 with time to progression over 4 months.

Figure 2b. A patient with breast cancer hepatic metastases had partial response in her hepatic disease with time to progression 11 months.